SFRP2 and colorectal carcinoma: Zhou et al25 reported that the suppression of SFRP2 inhibited CRC cell proliferation, migration, and invasion and that CRC patients with high SFRP2 expression had shorter overall survival times, recommending that SFRP2 could be a major prognostic marker in CRC.